Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-30 Sale | 2025-07-02 4:30 pm | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 781 | $5.04 | $3,936 | 82,807 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:36 pm | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 45,316 | $8.7606 | $396,995 | 279,004 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:36 pm | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 32,146 | $8.7623 | $281,673 | 127,349 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:35 pm | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 26,172 | $8.7737 | $229,624 | 225,740 (Direct) | View |
| 2025-03-17 Sale(A) | 2025-03-20 4:35 pm | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 31,278 | $8.8224 | $275,947 | 155,512 (Direct) | View |
| 2025-03-17 Sale | 2025-03-19 4:12 pm | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 31,278 | $8.8224 | $275,947 | 155,512 (Direct) | View |
| 2025-03-17 Sale | 2025-03-19 4:06 pm | Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks | 5,000 | $8.8338 | $44,169 | 38,038 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:30 pm | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 13,534 | $7.225 | $97,783 | 110,673 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:30 pm | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 14,322 | $7.225 | $103,476 | 96,790 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:30 pm | Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks | 9,511 | $7.225 | $68,717 | 43,038 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:30 pm | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 21,704 | $7.225 | $156,811 | 251,912 (Direct) | View |
| 2025-01-15 Sale | 2025-01-17 4:30 pm | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 10,428 | $7.225 | $75,342 | 79,320 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 4:30 pm | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 13,673 | $8.2182 | $112,367 | 124,207 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-30 Exercise | 2025-07-02 4:30 pm | N/A 2033-04-28 | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 781 | $0 | 82,807 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:30 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 781 | $1.29 | 82,807 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 08:30 am | N/A N/A | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 5,353 | $4.67 | 90,865 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 08:30 am | N/A N/A | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 42,826 | $4.67 | 268,566 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 08:30 am | N/A N/A | Candel Therapeutics Inc. | CADL | Manning Paul B Director | 1,070,663 | $4.67 | 5,197,821 (Indirect) | View |
| 2025-06-25 Option Award | 2025-06-26 08:30 am | N/A N/A | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 111,349 | $4.67 | 546,863 (Indirect) | View |
| 2025-06-25 Option Award | 2025-06-26 08:30 am | N/A N/A | Candel Therapeutics Inc. | CADL | Loggia Nicoletta Director | 2,141 | $4.67 | 2,141 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 08:30 am | N/A N/A | Candel Therapeutics Inc. | CADL | Schoch Charles Chief Financial Officer | 5,353 | $4.67 | 43,391 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 08:30 am | N/A N/A | Candel Therapeutics Inc. | CADL | Nabel Gary J. Director | 5,353 | $4.67 | 5,353 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 08:30 am | N/A N/A | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 4,282 | $4.67 | 100,809 (Direct) | View |
| 2025-06-25 Option Award | 2025-06-26 08:30 am | N/A N/A | Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director | 64,239 | $4.67 | 102,271 (Indirect) | View |
| 2025-06-20 Option Award | 2025-06-24 4:30 pm | N/A 2035-06-20 | Candel Therapeutics Inc. | CADL | Schoch Charles Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 08:38 am | N/A 2035-06-17 | Candel Therapeutics Inc. | CADL | Benz Edward J. JR Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 08:37 am | N/A 2035-06-17 | Candel Therapeutics Inc. | CADL | Gaeta Renee Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 08:36 am | N/A 2035-06-17 | Candel Therapeutics Inc. | CADL | Loggia Nicoletta Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 08:35 am | N/A 2035-06-17 | Candel Therapeutics Inc. | CADL | Manning Paul B Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 08:34 am | N/A 2035-06-17 | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 08:33 am | N/A 2035-06-17 | Candel Therapeutics Inc. | CADL | Nabel Gary J. Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 08:33 am | N/A 2035-06-17 | Candel Therapeutics Inc. | CADL | Nguyen Diem Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-18 08:32 am | N/A 2035-06-17 | Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 4:36 pm | N/A 2035-06-04 | Candel Therapeutics Inc. | CADL | Radhakrishnan Maha Director | 28,480 | $0 | 28,480 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:36 pm | N/A 2032-09-12 | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 18,489 | $0 | 279,004 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:36 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 13,905 | $1.29 | 279,004 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:36 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 4,584 | $3.75 | 279,004 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:36 pm | N/A 2030-12-30 | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 18,000 | $0 | 127,349 (Direct) | View |
| 2025-03-18 Exercise | 2025-03-20 4:36 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 18,000 | $1.55 | 127,349 (Direct) | View |
| 2025-03-17 Exercise(A) | 2025-03-20 4:35 pm | N/A 2033-04-28 | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 20,000 | $0 | 155,512 (Direct) | View |
| 2025-03-17 Exercise(A) | 2025-03-20 4:35 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 20,000 | $1.29 | 155,512 (Direct) | View |
| 2025-03-17 Exercise | 2025-03-19 4:12 pm | N/A 2033-04-28 | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 20,000 | $0 | 155,512 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:30 pm | N/A 2035-02-12 | Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks | 83,000 | $0 | 83,000 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:30 pm | N/A 2035-02-12 | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 107,250 | $0 | 107,250 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:30 pm | N/A 2035-02-12 | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:30 pm | N/A 2035-02-12 | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 525,000 | $0 | 525,000 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:30 pm | N/A 2035-02-12 | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 115,000 | $0 | 115,000 (Direct) | View |